• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

椎基底动脉疾病血流动力学的自然史:VERiTAS 研究队列的时间变化。

Natural History of Hemodynamics in Vertebrobasilar Disease: Temporal Changes in the VERiTAS Study Cohort.

机构信息

Department of Neurosurgery (S.A.-H., A.P.S., X.D., L.R.-F., F.T.C.), University of Illinois at Chicago.

Department of Neurology and Rehabilitation (D.K.P.), University of Illinois at Chicago.

出版信息

Stroke. 2020 Nov;51(11):3295-3301. doi: 10.1161/STROKEAHA.120.029909. Epub 2020 Oct 9.

DOI:10.1161/STROKEAHA.120.029909
PMID:33032489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7606530/
Abstract

BACKGROUND AND PURPOSE

The role of regional hypoperfusion as a contributor to stroke risk in atherosclerotic vertebrobasilar disease has recently been confirmed by the observational VERiTAS (Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke) Study. We examined the stability of hemodynamic status over time and its relationship to stroke risk in patients from this prospective cohort.

METHODS

VERiTAS enrolled patients with recently symptomatic ≥50% atherosclerotic stenosis/occlusion of vertebral and/or basilar arteries. Large vessel flow in the vertebrobasilar territory was assessed using quantitative magnetic resonance angiography, and patients were designated as low or normal flow based on distal territory regional flow, incorporating collateral capacity. Patients underwent standard medical management and follow-up for primary outcome event of vertebrobasilar territory stroke. Quantitative magnetic resonance angiography imaging was repeated at 6, 12, and 24 months. Flow status over time was examined relative to baseline and relative to subsequent stroke risk using a cause-specific proportional hazard model, with flow status treated as a time-varying covariate. Mean blood pressure was examined to assess for association with changes in flow status.

RESULTS

Over 19±8 months of follow-up, 132 follow-up quantitative magnetic resonance angiography studies were performed in 58 of the 72 enrolled patients. Of the 13 patients with serial imaging who had low flow at baseline, 7 (54%) had improvement to normal flow at the last follow-up. Of the 45 patients who had normal flow at baseline, 3 (7%) converted to low flow at the last follow-up. The mean blood pressure did not differ in patients with or without changes in flow status. The time-varying flow status remained a strong predictor of subsequent stroke (hazard ratio, 10.3 [95% CI, 2.2-48.7]).

CONCLUSIONS

There is potential both for improvement and worsening of hemodynamics in patients with atherosclerotic vertebrobasilar disease. Flow status, both at baseline and over time, is a risk factor for subsequent stroke, thus serving as an important prognostic marker. Registration: URL: https://clinicaltrials.gov. Unique identifier: NCT00590980.

摘要

背景与目的

最近通过观察性 VERiTAS(椎动脉血流评估及短暂性脑缺血发作和卒中风险)研究证实,区域性低灌注在粥样硬化性椎基底动脉疾病导致的卒中风险中发挥作用。我们通过这项前瞻性队列研究,考察了患者的血流动力学状态随时间的稳定性及其与卒中风险的关系。

方法

VERiTAS 纳入了椎动脉和/或基底动脉存在近期有症状的≥50%粥样硬化性狭窄/闭塞的患者。通过定量磁共振血管造影评估椎基底动脉区域的大血管血流,根据远端区域血流(包含侧支循环能力)将患者分为低灌注或正常灌注。患者接受标准的医疗管理和随访,以评估椎基底动脉区域卒中的主要结局事件。在 6、12 和 24 个月时重复定量磁共振血管造影成像。使用基于事件的比例风险模型,根据基线和随后的卒中风险考察随时间变化的血流状态,将血流状态视为时变协变量。考察平均血压与血流状态变化之间的关联。

结果

在 19±8 个月的随访期间,72 例入组患者中的 58 例完成了 132 次随访定量磁共振血管造影研究。在基线时为低灌注的 13 例患者中,有 7 例(54%)在最后一次随访时改善为正常灌注。在基线时为正常灌注的 45 例患者中,有 3 例(7%)在最后一次随访时转为低灌注。有或无血流状态变化的患者之间平均血压无差异。时变血流状态仍然是随后卒中的强烈预测因素(风险比,10.3[95%CI,2.2-48.7])。

结论

在患有粥样硬化性椎基底动脉疾病的患者中,血流动力学可能会改善,也可能会恶化。血流状态,无论是在基线还是随时间变化,都是随后卒中的危险因素,因此是一个重要的预后标志物。登记信息:网址:https://clinicaltrials.gov。唯一标识符:NCT00590980。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b1/7606530/631710aafe66/nihms-1630483-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b1/7606530/631710aafe66/nihms-1630483-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b1/7606530/631710aafe66/nihms-1630483-f0001.jpg

相似文献

1
Natural History of Hemodynamics in Vertebrobasilar Disease: Temporal Changes in the VERiTAS Study Cohort.椎基底动脉疾病血流动力学的自然史:VERiTAS 研究队列的时间变化。
Stroke. 2020 Nov;51(11):3295-3301. doi: 10.1161/STROKEAHA.120.029909. Epub 2020 Oct 9.
2
Hypoperfusion Symptoms Poorly Predict Hemodynamic Compromise and Stroke Risk in Vertebrobasilar Disease.椎基底动脉疾病中的灌注不足症状不能很好地预测血流动力学障碍和卒中风险。
Stroke. 2019 Feb;50(2):495-497. doi: 10.1161/STROKEAHA.118.023101.
3
Optimized Hemodynamic Assessment to Predict Stroke Risk in Vertebrobasilar Disease: Analysis From the VERiTAS Study.优化血流动力学评估预测椎基底动脉疾病卒中风险:VERiTAS 研究分析。
J Am Heart Assoc. 2020 Jun 16;9(12):e016406. doi: 10.1161/JAHA.120.016406. Epub 2020 Jun 5.
4
Higher Stroke Risk with Lower Blood Pressure in Hemodynamic Vertebrobasilar Disease: Analysis from the VERiTAS Study.血流动力学性椎基底动脉疾病中血压降低与更高的卒中风险:来自VERiTAS研究的分析
J Stroke Cerebrovasc Dis. 2017 Feb;26(2):403-410. doi: 10.1016/j.jstrokecerebrovasdis.2016.09.044. Epub 2016 Oct 28.
5
Effect of Hemodynamics on Stroke Risk in Symptomatic Atherosclerotic Vertebrobasilar Occlusive Disease.血流动力学对有症状的动脉粥样硬化性椎基底动脉闭塞性疾病中风风险的影响。
JAMA Neurol. 2016 Feb;73(2):178-85. doi: 10.1001/jamaneurol.2015.3772.
6
Hemodynamic Features of Symptomatic Vertebrobasilar Disease.有症状的椎基底动脉疾病的血流动力学特征
Stroke. 2015 Jul;46(7):1850-6. doi: 10.1161/STROKEAHA.115.009215. Epub 2015 May 14.
7
Infarct Patterns in Patients with Atherosclerotic Vertebrobasilar Disease in Relation to Hemodynamics.动脉粥样硬化性椎基底动脉疾病患者梗死模式与血流动力学的关系
Cerebrovasc Dis Extra. 2019;9(3):123-128. doi: 10.1159/000503091. Epub 2019 Oct 16.
8
Cost-Effectiveness of Quantitative Magnetic Resonance Angiography Screening and Submaximal Angioplasty for Symptomatic Vertebrobasilar Disease.定量磁共振血管造影筛查和次最大血管成形术治疗症状性椎基底动脉疾病的成本效益分析。
Stroke. 2018 Aug;49(8):1953-1959. doi: 10.1161/STROKEAHA.118.022339.
9
Angiography-based hemodynamic features predict recurrent ischemic events after angioplasty and stenting of intracranial vertebrobasilar atherosclerotic stenosis.基于血管造影的血流动力学特征可预测颅内椎基底动脉粥样硬化性狭窄血管成形术和支架置入后的复发性缺血事件。
Eur Radiol. 2024 Apr;34(4):2352-2363. doi: 10.1007/s00330-023-10209-x. Epub 2023 Sep 19.
10
Perfusion-MRI is a Poor Indicator of Hemodynamic Compromise in Vertebrobasilar Disease in the VERiTAS Study.灌注磁共振成像(MRI)在 VERiTAS 研究中对椎基底动脉疾病的血流动力学障碍的指示作用较差。
J Neuroimaging. 2021 Jan;31(1):151-154. doi: 10.1111/jon.12802. Epub 2020 Nov 4.

引用本文的文献

1
Indications, operative techniques, and outcomes of occipital artery-vertebral artery bypass: an institutional series.枕动脉-椎动脉旁路术的适应证、手术技术和结果:一个机构系列。
Acta Neurochir (Wien). 2024 Aug 7;166(1):329. doi: 10.1007/s00701-024-06210-y.
2
Bypass grafting to the third segment of the vertebral artery for symptomatic extensive vertebrobasilar atherosclerotic disease.针对有症状的广泛性椎基底动脉粥样硬化疾病,行椎动脉第三段旁路移植术。
J Vasc Surg Cases Innov Tech. 2023 Jul 5;9(3):101260. doi: 10.1016/j.jvscit.2023.101260. eCollection 2023 Sep.
3
Vascular flow limitations affecting the cervico-cranial region: Understanding ischaemia.

本文引用的文献

1
One-Year Risk of Recurrent Stroke and Death Associated with Vertebrobasilar Artery Stenosis and Occlusion in a Cohort of 10,515 Patients.10515 例患者队列中椎基底动脉狭窄和闭塞与复发性卒中及死亡的 1 年风险。
Cerebrovasc Dis. 2019;47(1-2):40-47. doi: 10.1159/000495418. Epub 2019 Feb 14.
2
Effect of statin on progression of symptomatic basilar artery stenosis and subsequent ischemic stroke.他汀类药物对症状性基底动脉狭窄进展及随后缺血性卒中的影响。
PLoS One. 2017 Oct 11;12(10):e0183798. doi: 10.1371/journal.pone.0183798. eCollection 2017.
3
Hemodynamics and oxygen extraction in chronic large artery steno-occlusive disease: Clinical applications for predicting stroke risk.
影响颈颅区域的血管血流限制:理解缺血。
Braz J Phys Ther. 2023 May-Jun;27(3):100493. doi: 10.1016/j.bjpt.2023.100493. Epub 2023 Mar 17.
4
Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.优化卒中和相关心脏病管理的综合护理:欧洲心脏病学会卒中委员会立场文件。
Eur Heart J. 2022 Jul 7;43(26):2442-2460. doi: 10.1093/eurheartj/ehac245.
5
Regulation of Blood Flow in the Cerebral Posterior Circulation by Parasympathetic Nerve Fibers: Physiological Background and Possible Clinical Implications in Patients With Vertebrobasilar Stroke.副交感神经纤维对脑后循环血流的调节:生理背景及对椎基底动脉卒中患者的潜在临床意义
Front Neurol. 2021 Oct 29;12:660373. doi: 10.3389/fneur.2021.660373. eCollection 2021.
6
New Insight Into Neutrophils: A Potential Therapeutic Target for Cerebral Ischemia.中性粒细胞新视角:脑缺血的潜在治疗靶点。
Front Immunol. 2021 Jul 14;12:692061. doi: 10.3389/fimmu.2021.692061. eCollection 2021.
慢性大动脉狭窄性闭塞性疾病的血液动力学和氧摄取:预测卒中风险的临床应用。
J Cereb Blood Flow Metab. 2018 Sep;38(9):1584-1597. doi: 10.1177/0271678X17732884. Epub 2017 Sep 19.
4
Stenting for symptomatic vertebral artery stenosis: The Vertebral Artery Ischaemia Stenting Trial.症状性椎动脉狭窄的支架置入术:椎动脉缺血支架置入试验
Neurology. 2017 Sep 19;89(12):1229-1236. doi: 10.1212/WNL.0000000000004385. Epub 2017 Aug 23.
5
Reconsideration of Hemodynamic Cerebral Ischemia Using Recent PET/SPECT Studies.利用近期正电子发射断层扫描/单光子发射计算机断层扫描研究重新审视脑血流动力学缺血
Acta Neurochir Suppl. 2016;123:99-108. doi: 10.1007/978-3-319-29887-0_14.
6
Relative Mean Transit Time Predicts Subsequent Stroke in Symptomatic Carotid Occlusion.相对平均通过时间可预测症状性颈动脉闭塞患者随后发生卒中的情况。
J Stroke Cerebrovasc Dis. 2016 Jun;25(6):1421-4. doi: 10.1016/j.jstrokecerebrovasdis.2015.12.041. Epub 2016 Mar 22.
7
Effect of Hemodynamics on Stroke Risk in Symptomatic Atherosclerotic Vertebrobasilar Occlusive Disease.血流动力学对有症状的动脉粥样硬化性椎基底动脉闭塞性疾病中风风险的影响。
JAMA Neurol. 2016 Feb;73(2):178-85. doi: 10.1001/jamaneurol.2015.3772.
8
Risks of stenting in patients with extracranial and intracranial vertebral artery stenosis.颅外和颅内椎动脉狭窄患者的支架置入风险。
Lancet Neurol. 2015 Sep;14(9):875. doi: 10.1016/S1474-4422(15)00142-8.
9
Hemodynamic Features of Symptomatic Vertebrobasilar Disease.有症状的椎基底动脉疾病的血流动力学特征
Stroke. 2015 Jul;46(7):1850-6. doi: 10.1161/STROKEAHA.115.009215. Epub 2015 May 14.
10
Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.球囊扩张颅内支架与药物治疗对症状性颅内狭窄患者卒中风险的影响:VISSIT 随机临床试验。
JAMA. 2015;313(12):1240-8. doi: 10.1001/jama.2015.1693.